Cargando…
Prevalence of Empiric Antibacterial Therapy, Community-Acquired Bacterial Superinfection, and Antibiotic-Associated Adverse Reactions among Patients with COVID-19 Pneumonia Admitted in Makati Medical Center from March 2020 to March 2021
BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus which was first discovered in Wuhan, China. Being a viral illness, antibacterial agents theoretically have no role in patients with pure COVID-19 infection. However, like any viral illness, concomitant bacterial infec...
Autores principales: | Galang – De Leon, Waiva Ann M., Buensalido, Joseph Adrian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259919/ https://www.ncbi.nlm.nih.gov/pubmed/35706084 http://dx.doi.org/10.3947/ic.2022.0014 |
Ejemplares similares
-
69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER
por: Macatangay, M.V.R., et al.
Publicado: (2022) -
In the Limelight: March 2021
por: Nath, Karl A.
Publicado: (2021) -
Editorial March 2021
por: Ishwaran, Natarajan
Publicado: (2021) -
Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021
por: Chua, Kao-Ping, et al.
Publicado: (2022) -
Reported exposure trends among healthcare personnel COVID-19 cases, USA, March 2020–March 2021
por: Billock, Rachael M., et al.
Publicado: (2022)